MiMedx Stock Forecast - Naive Prediction
| MDXG Stock | USD 9.22 0.16 1.77% |
The Naive Prediction forecasted value of MiMedx Group on the next trading day is expected to be 9.45 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 11.00. MiMedx Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of MiMedx's historical fundamentals, such as revenue growth or operating cash flow patterns.
MiMedx |
MiMedx Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the MiMedx's financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2007-03-31 | Previous Quarter 69 M | Current Value 88.8 M | Quarterly Volatility 814.9 M |
MiMedx Naive Prediction Price Forecast For the 23rd of November
Given 90 days horizon, the Naive Prediction forecasted value of MiMedx Group on the next trading day is expected to be 9.45 with a mean absolute deviation of 0.18, mean absolute percentage error of 0.06, and the sum of the absolute errors of 11.00.Please note that although there have been many attempts to predict MiMedx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MiMedx's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
MiMedx Stock Forecast Pattern
| Backtest MiMedx | MiMedx Price Prediction | Buy or Sell Advice |
MiMedx Forecasted Value
In the context of forecasting MiMedx's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. MiMedx's downside and upside margins for the forecasting period are 5.08 and 13.81, respectively. We have considered MiMedx's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of MiMedx stock data series using in forecasting. Note that when a statistical model is used to represent MiMedx stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.1963 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1773 |
| MAPE | Mean absolute percentage error | 0.0261 |
| SAE | Sum of the absolute errors | 10.995 |
Predictive Modules for MiMedx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MiMedx Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for MiMedx
For every potential investor in MiMedx, whether a beginner or expert, MiMedx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MiMedx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MiMedx. Basic forecasting techniques help filter out the noise by identifying MiMedx's price trends.View MiMedx Related Equities
| Risk & Return | Correlation |
MiMedx Group Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of MiMedx's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of MiMedx's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MiMedx Market Strength Events
Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns.
MiMedx Risk Indicators
The analysis of MiMedx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MiMedx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mimedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.24 | |||
| Semi Deviation | 1.77 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.61 | |||
| Downside Variance | 5.52 | |||
| Semi Variance | 3.14 | |||
| Expected Short fall | (2.69) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.1) | Earnings Share 0.57 | Revenue Per Share 2.447 | Quarterly Revenue Growth 0.029 | Return On Assets 0.1838 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.